 |
|
adenovirus encoding recombinant human endostatin
A replication-defective, recombinant oncolytic adenovirus encoding human endostatin with potential antineoplastic activity. Endostatin, a 20 kDa C-terminal proteolytic fragment of collagen XVIII, is an important angiogenesis inhibitor. Upon intratumoral administration, the adenovirus infects and replicates in tumor cells. The expressed endostatin may inhibit endothelial cell proliferation and angiogenesis which may result in a reduction of tumor growth. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Abbreviation: | | Ad-rhENDO | | | | Code name: | | E10A | | |
| Previous: | adenovector encoding MDA7, adenoviral vector encoding HSV thymidine kinase, adenovirus 5-tumor necrosis factor alpha, adenovirus B7-1, adenovirus encoding human aquaporin-1 | | Next: | adenovirus HER2-transduced autologous dendritic cell vaccine, adenovirus vector, adenovirus-interferon-gamma TG1042, ADH-1, adipose-derived regenerative cells |
|
|
